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Left ventricular myocardial deformation and
mechanical dyssynchrony in children with normal
ventricular shortening fraction after
anthracycline therapy
Yiu-fai Cheung, Wen-jing Hong, Godfrey C F Chan, Sophia J Wong, Shau-yin Ha
ABSTRACT
Objective The M-mode-derived left ventricular
shortening fraction is incorporated into most of the
paediatric oncology protocols for monitoring of
cardiotoxicity. This study tested the hypothesis that
alteration of left ventricular myocardial deformation and
mechanical dyssynchrony may occur in asymptomatic
children after anthracycline therapy despite having left
ventricular shortening fractions within the limits of
normal.
Design Cross-sectional study.
Setting Tertiary paediatric cardiac centre.
Methods Left ventricular longitudinal, circumferential
and radial myocardial deformation was determined using
speckle tracking echocardiography in 45 patients aged
15.365.8 years. Real-time three-dimensional
echocardiographic data were acquired for the
measurement of left ventricular volumes and systolic
dyssynchrony index (SDI), the latter derived from the
dispersion of time-to-minimum regional volume using
a 16-segment model. The results were compared with
those of 44 controls.
Results Compared with controls, patients had reduced
left ventricular global systolic longitudinal strain
(p¼0.012), circumferential strain (p<0.001), radial strain
(p¼0.006) and circumferential strain rate (SR; p¼0.002).
The cumulative anthracycline dose correlated negatively
with global longitudinal (r¼0.33, p¼0.027) and
circumferential (r¼0.32, p¼0.035) SR. The left
ventricular SDI was significantly greater in patients than
controls (4.4661.52% vs 3.8060.58%, p¼0.03). The
prevalence of left ventricular mechanical dyssynchrony
(SDI >4.96%) in patients was 16% (95% CI 6% to 29%).
In patients, SDI correlated negatively with left ventricular
ejection fraction (r¼0.52, p<0.001), radial strain
(r¼0.35, p¼0.021), circumferential strain (r¼0.37,
p¼0.015) and circumferential SR (r¼0.43, p¼0.004),
but not with the cumulative anthracycline dose
(p¼0.82).
Conclusions Impaired left ventricular myocardial
deformation and mechanical dyssynchrony may exist in
children after anthracycline therapy despite having
normal left ventricular shortening fractions.
Whereas anthracyclines have been widely used for the
treatment of childhood malignancies, the side-effect
of cardiotoxicity remains an issue of concern.1e5 Left
ventricular abnormalities are characterised by reduced
ventricular mass, increased afterload and impaired
contractility.3 Importantly, a recent study showed
that even children who have received a cumulative
doxorubicin dose as low as 45 mg/m2 have reduced
left ventricular mass,3 implying the absence of a safe
dose that is free of cardiotoxicity.
The M-mode-derived parameter of the left
ventricular shortening fraction is incorporated into
most of the paediatric oncology protocols for the
monitoring of cardiotoxicity.4 This parameter is
nonetheless limited to an assessment of radial
contraction of two left ventricular segments,
namely the mid-anteroseptal and mid-inferolateral
segments. The importance of assessing not only the
radial but also the longitudinal and circumferential
myocardial deformation of the left ventricle has
recently been increasingly acknowledged.6 Further-
more, segmental wall motion abnormalities found
during and after anthracycline therapy may not be
detectable by simply assessing the left ventricular
shortening fraction.7 A shortening fraction that is
within ‘normal’ limits may not thus always be
reassuring.
The recently introduced speckle tracking echocar-
diography (STE) allows angle-independent quantifi-
cation of myocardial deformation in different
dimensions,8 while three-dimensional echocardiog-
raphy has revolutionised the understanding of the
synchronous contraction of different left ventricular
segments in health and disease.9 In the present study,
we tested the hypothesis that an alteration of left
ventricular myocardial deformation and mechanical
dyssynchrony may occur in asymptomatic children
after anthracycline therapy despite having left
ventricular shortening fractions within the limits of
normal.
METHODS
Subjects
Forty-five children with acute lymphoblastic
leukaemia who had been off treatment for at least
1 year and who had a left ventricular shortening
fraction within normal limits (>28%) were
recruited. The cumulative dose of anthracyclines
received and the surface ECG findings were noted.
The echocardiographic findings of these patients
were compared with those of 44 control subjects,
who were healthy siblings of patients and children
with functional heart murmur, non-specific chest
pain or palpitation attending the cardiac outpatient
clinic, for which no underlying organic causes were
identified. The body weight and height of all
subjects were measured and the body surface area
was calculated accordingly.
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Conventional echocardiographic assessment
All echocardiographic assessments were performed using the
Vivid 7 ultrasound machine (GE Medical Systems, Horten,
Norway). The average value of the echocardiographic indices
from three cardiac cycles was used for analyses.
Standard M-mode assessment of the mid-left ventricular
parasternal short axis was performed to derive the following
parameters: left ventricular end-systolic and end-diastolic
dimensions; thickness of interventricular septum and posterior
left ventricular wall; left ventricular mass indexed for body
surface area and shortening fraction. Pulsed-wave Doppler
examination was performed to obtain peak mitral inflow
velocities at early (E) and late (A) diastole and early deceleration
time.
Tissue Doppler echocardiography was performed with the
sample volume positioned at the basal left ventricular free
wallemitral annular junction to obtain the following: peak early
(e) and late (a) diastolic myocardial tissue velocities, e/a ratio,
and peak systolic myocardial tissue velocity (s).
Speckle tracking echocardiography
STE for the determination of left ventricular strain and strain
rate (SR) was performed as reported previously.10 The four-
chamber apical plane was used to assess left ventricular longi-
tudinal strain and SR, whereas the short-axis plane at the level
of the papillary muscles was used to assess left ventricular radial
strain and circumferential strain and SR. Customised EchoPAC
software (GE Medical Systems) was used to track speckles
within the region of interest throughout the cardiac cycle for the
derivation of systolic strain and SR. For quantification of
regional myocardial deformation, the left ventricular free wall
and ventricular septum were divided into three segments,
whereas the left ventricular short-axis plane was divided into six
segments. For the calculation of global longitudinal, circumfer-
ential and radial deformation, the entire traced left ventricular
contours in the four-chamber and short-axis planes were used.
We and others have previously reported on low intra and
interobserver variability for the measurement of global longitu-
dinal strain and SR.11 12
Three-dimensional echocardiography
Real-time three-dimensional echocardiographic imaging was
performed from the apical view using a matrix array transducer
(Vivid 7 ultrasound system; General Electric, Vingmed, Horten,
Norway). Full-volume acquisition of the left ventricle was
performed during breathhold. Offline analyses of three-dimen-
sional datasets were performed using commercial four-dimensional
analysis software (Tomtec Imaging Systems, Unterschleisheim,
Germany). Quantitative analysis of the left ventricle involved the
definition of two, three and four-chamber planes through the
three-dimensional dataset at end-systole and end-diastole. The
endocardial border was traced with a semi-automated detection
process and a left ventricular cast was created for the derivation of
left ventricular end-diastolic and end-systolic volumes and ejection
fraction. By dividing this cast into pyramidal subvolumes based
around a non-fixed central point, the timeevolume data corre-
sponding to each of the 16 standard myocardial segments, as
defined by the American Society of Echocardiography,13 were
obtained. A systolic dyssynchrony index (SDI), defined as the SD
of the time taken to reach minimum regional volume for each of
the segments as a percentage of the cardiac cycle, was calculated to
quantify global left ventricular mechanical dyssynchrony.9 We
have similarly reported low intra and interobserver variability for
measurement of left ventricular SDI.14
Statistical analysis
All data are presented as means6SD. The demographic and
echocardiographic parameters of patients were compared with
those of control subjects using Student’s t test. The left
ventricular volumes were normalised by body surface area, and
absolute values of systolic strain and SR were presented. Global
left ventricular mechanical dyssynchrony was defined by left
ventricular SDI exceeding the mean +2 SD as derived from
control data. Pearson correlation analysis was used to assess
relationships between deformation parameters and the cumu-
lative anthracycline dose. A p value less than 0.05 is considered
statistically significant. All statistical analyses were performed
using SPSS version 11.5.
RESULTS
The 45 patients (28 males), aged 15.365.8 years had all received
anthracycline, doxorubicin or daunorubicin, as part of a chemo-
therapeutic regimen for the treatment of acute lymphoblastic
leukaemia. The median cumulative anthracycline dose was
240 mg/m2 (range 120e470 mg/m2). None of the patients
required cardiac irradiation. The patients were studied at
a median of 6.3 years (range 2.7e19.8 years) after the last dose of
anthracyclines. All of the patients had a sinus rhythm and none
had prolongation of QRS duration. All patients were asymp-
tomatic without the need for cardiac medications. The 44
controls (21 males) were aged 16.466.9 years (p¼0.40). The
weight (49.7616.6 kg vs 48.6616.8 kg, p¼0.76) and body mass
index (21.564.9 kg/m2 vs 19.964.0 kg/m2, p¼0.10) were similar
between patients and controls. None of our patients had
Doppler indices suggestive of left ventricular restrictive or
relaxation abnormalities.
Conventional echocardiographic parameters
Table 1 summarises the echocardiographic findings in patients and
controls. Albeit within the limits of normal, the left ventricular
shortening fraction was slightly but significantly lower in
patients than controls (p¼0.001). Compared with controls,
patients had significantly greater left ventricular end-systolic
Table 1 Comparison of echocardiographic indices between patients
and controls
Patients Controls
p Value(n[45) (n[44)
M-mode measurements
LVDD (cm) 4.660.5 4.560.5 0.30
LVDS (cm) 3.060.4 2.860.4 0.03*
Shortening fraction (%) 34.563.3 36.963.7 0.001*
Indexed left ventricular mass (g/m2) 45.9610.2 54.1611.9 0.001*
Mitral inflow Doppler indexes
E (cm/s) 100.0619.9 103.5621.5 0.49
A (cm/s) 52.2612.6 52.7615.0 0.87
E/A ratio 2.060.5 2.160.6 0.55
E deceleration time (ms) 130.3618.2 126.5627.6 0.45
Mitral annular myocardial tissue velocities
s (cm/s) 9.862.0 10.762.0 0.037*
e (cm/s) 17.762.9 18.062.3 0.60
a (cm/s) 7.461.7 7.762.4 0.51
e/a ratio 2.560.7 2.560.6 0.95
A, peak mitral inflow velocity at late diastole; a, mitral annular late diastolic myocardial
tissue velocity; E, peak mitral inflow velocity at early diastole; e, mitral annular early
diastolic myocardial tissue velocity; LVDD, left ventricular dimension at diastole; LVDS, left
ventricular dimension at systole; s, mitral annular systolic myocardial tissue velocity.
*Statistically significant.
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dimension (p¼0.001), decreased indexed left ventricular mass
(p¼0.001) and reduced mitral annular systolic myocardial
velocity (p¼0.037). On the other hand, the mitral diastolic inflow
velocities and mitral annular diastolic myocardial tissue velocity
were similar between patients and controls (all p>0.05).
Myocardial strain and SR
The left ventricular longitudinal, radial and circumferential
regional systolic strain parameters of patients and controls are
shown in figure 1. The longitudinal systolic strain of the left
ventricular free wall was similar between patients and controls,
whereas that of the basal (p¼0.03) and mid (p¼0.03) septum
was lower in patients. The systolic radial strain of all of the six
segments was significantly lower in patients than controls (all
p<0.05). The segmental circumferential systolic strain was
lower for the anteroseptal (p<0.001), inferoseptal (p¼0.008),
inferior (p¼0.001) and anterior (p¼0.001) segments in patients
than controls.
Taking into account the deformation of all the regional
segments, the global systolic longitudinal (17.663.0% vs
19.062.2, p¼0.012), circumferential (14.562.9% vs 17.464.3,
p<0.001) and radial (40.1615.6% vs 50.0616.4%, p¼0.006)
strain was significantly lower in patients than controls.
With regard to SR, compared with controls, patients had
similar longitudinal (0.9560.18/s vs 1.0060.15/s, p¼0.16) but
lower circumferential systolic SR (0.9060.21/s vs 1.0660.28/s,
p¼0.002).
Of the global strain and SR parameters in patients, the
cumulative anthracycline dose correlated significantly with
global longitudinal (r¼0.33, p¼0.027) and circumferential
(r¼0.32, p¼0.035) SR, whereas the time from completion of
chemotherapy correlated with global longitudinal strain
(r¼0.33, p¼0.032) and SR (r¼0.33, p¼0.03).
Three-dimensional global left ventricular mechanical
dyssynchrony
The left ventricular SDI was significantly greater in patients
than controls (4.4661.52% vs 3.8060.58%, p¼0.03). Based on
control data, global left ventricular mechanical dyssynchrony
was defined as SDI greater than 4.96%. The prevalence of left
ventricular systolic dyssynchrony in patients was 16% (seven of
45) (95% CI 6% to 29%). Figure 2 shows examples of synchro-
nous and dyssynchronous contraction of different left ventric-
ular segments during systole in a control and a patient,
respectively.
In patients, SDI correlated negatively with three-dimensional
echocardiography-derived left ventricular ejection fraction
(r¼0.52, p<0.001), global systolic radial (r¼0.35, p¼0.021)
and circumferential (r¼0.37, p¼0.015) strain and global
circumferential systolic SR (r¼0.43, p¼0.004), but not with
age (p¼0.1), left ventricular shortening fraction (p¼0.58), global
longitudinal strain (p¼0.24) and SR (p¼0.22), time from
completion of chemotherapy (p¼0.82) or the cumulative dose of
anthracyclines (p¼0.82). Multiple regression analysis was used
to identify significant correlates of SDI in patients. The depen-
dent variables entered were those found to be significant by
univariate analysis as listed above. The left ventricular ejection
fraction was identified to be the only significant correlate
(b¼0.51, p<0.001).
DISCUSSION
Our findings suggest that children after anthracycline therapy,
albeit having left ventricular shortening fraction within normal
limits, may have reduced left ventricular myocardial deforma-
tion in all of the three dimensions. Importantly, dyssynchronous
left ventricular contraction was documented for the first time
using three-dimensional echocardiography in these children,
with a prevalence of 16% in our cohort. The present study
represents a paradigm shift in the monitoring of anthracycline
cardiotoxicity from conventional assessment of changes in the
left ventricular cavity dimension to direct assessment of
magnitude, rate and synchronicity of myocardial deformation.
While frequently incorporated into paediatric oncology
protocols for the monitoring of left ventricular systolic func-
tion,4 the M-mode-derived shortening fraction has its limita-
tions. Derivation of the left ventricular shortening fraction
depends on the method used to obtain left ventricular dimen-
sions,15 and values can vary considerably between different
observers.16 Additional issues include assessment being limited
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Figure 1 Comparisons of regional systolic longitudinal (upper panel),
radial (middle panel), and circumferential (lower panel) strain between
patients (black columns) and controls (white columns) (*p<0.05 vs
controls). LV, left ventricular.
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to the radial contraction of two myocardial segments and load
dependency. The incorporation of end-systolic wall stress in the
evaluation provides a means to adjust for the afterload, although
this has not been widely adopted in clinical practice.4 In patients
who may otherwise be regarded as having normal left ventric-
ular systolic function based on isolated M-mode findings, the
new echocardiographic techniques have unmasked evidence of
left ventricular systolic dysfunction, as characterised by reduced
and dyssynchronous systolic myocardial deformation.
Increasing data suggest that systolic strain and SR are strong
indices of ventricular contractility.17e19 It is worth noting that
the peak systolic SR, which represents the rate of myocardial
deformation, may even better reflect the rate of myocardial force
generation and hence contractility.18 20 Ganame et al21 have
reported on the reduction of predominantly longitudinal
regional strain and SR as determined by tissue Doppler imaging
in children after low-dose anthracycline (#300 mg/m2) therapy.
Nonetheless, the limitations of tissue Doppler imaging include
angle dependency, limitation of assessment of myocardial
deformation to one dimension and susceptibility to noisy arte-
facts.22 23 By contrast, STE has the advantages of angle inde-
pendence,24 the generation of more reproducible SR profiles,11
and allowing comprehensive assessment of both regional and
global left ventricular myocardial deformation in three dimen-
sions. The importance of assessing not only longitudinal but also
radial and circumferential myocardial deformation of the left
ventricle is increasingly acknowledged.6 Our findings suggest
that indices of radial and circumferential, in contrast to longi-
tudinal, deformation are perhaps more sensitive in the detection
of left ventricular systolic dysfunction after anthracycline
therapy (figure 1). Indeed, the more sensitive nature of circum-
ferential deformation has been shown in adults with myocardial
ischaemia.25
Notwithstanding the lack of data on left ventricular mechan-
ical dyssynchrony in patients after anthracycline therapy, two
recent case reports suggested a favourable effect of cardiac
resynchronisation therapy (CRT) on anthracyline-induced cardi-
otoxicity in patients with normal QRS duration. The first
described the prompt improvement of left ventricular ejection
fraction in a 9-year-old girl who developed acute heart failure
during chemotherapy for acute myeloid leukaemia,26 whereas the
second reported on the normalisation of left ventricular ejection
fraction in a 46-year-old woman who developed severe heart
failure after completion of chemotherapy for breast cancer.27 In
another small series of four adults with doxorubicin-induced
cardiomyopathy in association with left bundle branch block and
prolonged QRS duration, the impact of CRT-induced left
ventricular reverse remodelling was reported to sustain over
a mean follow-up duration of 18.5 months.28 Although these
anecdotal reports appear encouraging, the prevalence, correlates
and clinical implication of left ventricular mechanical dyssyn-
chrony in patients after anthracyline therapy remain unclear. To
our knowledge, this is the first study to explore mechanical
dyssynchrony by three-dimensional echocardiography in children
after anthracycline therapy.
In our asymptomatic patient cohort, the finding of a 16%
prevalence of left ventricular mechanical dyssynychrony is
intriguing. The abnormal SDI has clinical implications as shown by
its negative correlations with left ventricular ejection fraction and
myocardial deformation in the circumferential and radial dimen-
sions. Similar to the two reported patients,26 27 our patients had
normal QRS duration and absence of left bundle branch block.
Therefore, electrical dyssynchrony is unlikely to be the culprit.
Multifocal areas of patchy interstitial fibrosis are characteristic
features of myocardial biopsies from patients with anthracycline
cardiomyopathy.29 An ovine model of anthracycline-induced
cardiotoxicity has revealed the heterogeneous distribution of left
ventricular fibrosis based on histology and late gadolinium
enhancement on cardiac magnetic resonance.30 Segmental fibrosis
of the left ventricle in vivo has indeed been suggested by suben-
docardial late gadolinium enhancement in adults with anthracy-
cline cardiotoxicity following treatment for Ewing’s sarcoma.31 It is
possible, albeit speculative, that non-uniform alteration of left
ventricular myocardium by anthracycline may contribute to left
ventricular mechanical dyssynchrony. The magnitude of mechan-
ical dyssynchrony is not, however, related to the cumulative
anthracycline dose or the time from completion of chemotherapy.
Taken together, the present findings can perhaps provide further
rationale for the consideration of CRT in patients with refractory
left ventricular failure after anthracycline therapy.
In the present study, we have limited cardiac assessment to
patients who had been off treatment for at least 1 year. Further
application of these new techniques in echocardiographic
Figure 2 Regional volume curves, normalised to individual maximum,
demonstrating (A) dyssynchronous contraction of multiple segments in
a patient and (B) synchronous contraction in the 16 left ventricular
segments in a control.
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surveillance during the administration of chemotherapy might
facilitate the early detection of myocardial dysfunction for
timely intervention. Longitudinal studies are nonetheless
required to provide evidence as to whether this approach would
alter the course of anthracycline-induced cardiomyopathy.
Several limitations to this study warrant comment. The cross-
sectional nature of the present study does not provide informa-
tion on the value of myocardial deformation and dyssynchrony
parameters in prognostication, an issue that requires clarification
by longitudinal studies. Second, we have not calculated the global
radial SR, as averaging of the radial SR of the six segments is not
feasible with the present version of the software. Third, although
STE allows interrogation of global strain and SR parameters in
the three dimensions, these parameters are not entirely load
dependent and need to be interpreted with caution when an
alteration of cardiac status with acute changes in load is antici-
pated. Changes in load are of particular relevance for our group of
patients, given the well-documented finding of increased afterload
secondary todecreasedwall thickness and leftventricularmass,1 3 32
which have been demonstrated to progress with time.3
In conclusion, a normal left ventricular shortening fraction in
children after anthracycline therapy may not be completely
reassuring, and an assessment of the magnitude, rate and
synchronicity of myocardial deformation may provide additional
insights on the alteration of left ventricular mechanics.
Funding This study is supported by the Children’s Cancer Foundation and CRCG
funding, the University of Hong Kong.
Competing interests None.
Ethics approval This study was conducted with the approval of the institutional
review board of the University of Hong Kong/Hospital Authority Hong Kong West
Cluster, Hong Kong.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy
for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808e15.
2. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and drug dose as risk factors
for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med
1995;332:1738e43.
3. Lipshultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction
years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin
Oncol 2005;23:2629e36.
4. van Dalen EC, van den Brug M, Caron HN, et al. Anthracycline-induced
cardiotoxicity: comparison of recommendations for monitoring cardiac function during
therapy in paediatric oncology trials. Eur J Cancer 2006;42:3199e205.
5. Elbl L, Hrstkova H, Tomaskova I, et al. Long-term serial echocardiographic
examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in
paediatric patients. Eur J Pediatr 2005;164:678e84.
6. Arita T, Sorescu GP, Schuler BT, et al. Speckle-tracking strain echocardiography for
detecting cardiac dyssynchrony in a canine model of dyssynchrony and heart failure.
Am J Physiol Heart Circ Physiol 2007;293:H735e42.
7. Kapusta L, Groot-Loonen J, Thijssen JM, et al. Regional cardiac wall motion
abnormalities during and shortly after anthracycline therapy. Med Pediatr Oncol
2003;41:426e35.
8. Leitman M, Lysyansky P, Sidenko S, et al. Two-dimensional strainda novel
software for real-time quantitative echocardiographic assessment of myocardial
function. J Am Soc Echocardiogr 2004;17:1021e9.
9. Kapetanakis S, Kearney MT, Siva A, et al. Real-time three-dimensional
echocardiography: a novel technique to quantify global left ventricular mechanical
dyssynchrony. Circulation 2005;112:992e1000.
10. Cheung EW, Liang XC, Lam WW, et al. Impact of right ventricular dilation on left
ventricular myocardial deformation in patients after surgical repair of tetralogy of
Fallot. Am J Cardiol 2009;104:1264e70.
11. Chow PC, Liang XC, Cheung EW, et al. New two-dimensional global longitudinal
strain and strain rate imaging for assessment of systemic right ventricular function.
Heart 2008;94:855e9.
12. Mavinkurve-Groothuis AM, Weijers G, Groot-Loonen, et al. Interobserver,
intraobserver and intrapatient reliability scores of myocardial strain imaging with 2-D
echocardiography in patients treated with anthracyclines. Ultrasound Med Biol
2009;35:697e704.
13. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial
segmentation and nomenclature for tomographic imaging of the heart: a statement
for healthcare professionals from the Cardiac Imaging Committee of the Council on
Clinical Cardiology of the American Heart Association. Circulation 2002;105:539e42.
14. Liang XC, Cheung EW, Wong SJ, et al. Impact of right ventricular volume overload
on three-dimensional global left ventricular mechanical dyssynchrony after surgical
repair of tetralogy of Fallot. Am J Cardiol 2008;102:1731e6.
15. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in
M-mode echocardiography: results of a survey of echocardiographic measurements.
Circulation 1978;58:1072e83.
16. Lipshultz SE, Easley KA, Orav EJ, et al. Reliability of multicenter pediatric
echocardiographic measurements of left ventricular structure and function: the
prospective P(2)C(2) HIV study. Circulation 2001;104:310e16.
17. Greenberg NL, Firstenberg MS, Castro PL, et al. Doppler-derived myocardial systolic
strain rate is a strong index of left ventricular contractility. Circulation
2002;105:99e105.
18. Pellerin D, Sharma R, Elliott P, et al. Tissue Doppler, strain, and strain rate
echocardiography for the assessment of left and right systolic ventricular function.
Heart 2003;89(Suppl 3):iii9e17.
19. Weidemann F, Jamal F, Kowalski M, et al. Can strain rate and strain quantify
changes in regional systolic function during dobutamine infusion, B-blockade, and
atrial pacingdimplications for quantitative stress echocardiography. J Am Soc
Echocardiogr 2002;15:416e24.
20. Weidemann F, Jamal F, Sutherland GR, et al. Myocardial function defined by strain
rate and strain during alterations in inotropic states and heart rate. Am J Physiol
Heart Circ Physiol 2002;283:H792e9.
21. Ganame J, Claus P, Uyttebroeck A, et al. Myocardial dysfunction late after low-dose
anthracycline treatment in asymptomatic pediatric patients. J Am Soc Echocardiogr
2007;20:1351e8.
22. Marwick TH. Measurement of strain and strain rate by echocardiography: ready for
prime time? J Am Coll Cardiol 2006;47:1313e27.
23. Ng AC, Tran da T, Newman M, et al. Comparison of myocardial tissue velocities
measured by two-dimensional speckle tracking and tissue Doppler imaging. Am J
Cardiol 2008;102:784e9.
24. Amundsen BH, Helle-Valle T, Edvardsen T, et al. Noninvasive myocardial strain
measurement by speckle tracking echocardiography: validation against sonomicrometry
and tagged magnetic resonance imaging. J Am Coll Cardiol 2006;47:789e93.
25. Tanaka H, Oishi Y, Mizuguchi Y, et al. Three-dimensional evaluation of dobutamine-
induced changes in regional myocardial deformation in ischemic myocardium using
ultrasonic strain measurements: the role of circumferential myocardial shortening.
J Am Soc Echocardiogr 2007;20:1294e9.
26. Jones BO, Davis AM, Alison J, et al. Cardiac re-synchronization therapy in a child
with severe anthracycline-induced congestive heart failure and normal QRS duration.
J Heart Lung Transplant 2007;26:1333e5.
27. Ahlehoff O, Galloe AM, Hansen PR. Anthracycline-induced cardiomyopathy:
favourable effects of cardiac resynchronization therapy. Int J Cardiol. Published Online
First: 8 Jan 2009. doi: 10.1016/j.ijcard.2008.11.194.
28. Ajijola OA, Nandigam KV, Chabner BA, et al. Usefulness of cardiac
resynchronization therapy in the management of doxorubicin-induced
cardiomyopathy. Am J Cardiol 2008;101:1371e2.
29. Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic
mechanisms to management. Prog Cardiovasc Dis 2007;49:330e52.
30. Psaltis PJ, Carbone A, Nelson AJ, et al. An ovine model of anthracycline-induced
cardiotoxicity e applicability as a pre-clinical surrogate for nonischaemic
cardiomyopathy. Heart Lung Circ 2009;18S:S169.
31. Perel RD, Slaughter RE, Strugnell WE. Subendocardial late gadolinium enhancement
in two patients with anthracycline cardiotoxicity following treatment for Ewing’s
sarcoma. J Cardiovasc Magn Reson 2006;8:789e91.
32. Sorensen K, Levitt G, Sebag-Monteflore D, et al. Cardiac function in Wilm’s tumor
survivors. J Clin Oncol 1995;13:1546e56.
Heart 2010;96:1137e1141. doi:10.1136/hrt.2010.194118 1141
Toxic myocardial injury
 group.bmj.com on October 26, 2010 - Published by heart.bmj.comDownloaded from 
